|
|
| |
Page: 1 2 3 4 5 6 7 8 9 10 |
Next >>
|
DNA ½ÃÄö½ÌÀÇ ±â¼ú, ½ÃÀå, ±â¾÷ DNA sequencing: technologies, markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| DNA ½ÃÄö½ÌÀÇ °¢Á¾ ±â¼ú¿¡ ´ëÇÑ ¹ßÀü µ¿ÇâÀ» Á¶»ç ºÐ¼®Çϰí, ±âÁ¸ ±â¼ú°ú ½Å±â¼úÀÇ °³¿ä, °¢Á¾ ¾ÖÇø®ÄÉÀ̼Ç, °ü·Ã ±â¾÷/¿¬±¸±â°üÀÇ µ¿Çâ, ½ÃÀå±Ô¸ð ºÐ¼®, ½ÃÀ强Àå¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ, °¢Á¾ Á¦¾ð µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
ºÐÀÚÁø´Ü : ±â¼ú, ½ÃÀå, ±â¾÷ Molecular Diagnostics - Technologies, Markets and Companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ÀÇ·áȰµ¿, °øÁßÀ§»ý, ÀǾàǰ »ê¾÷, ¹ýÀÇÇÐ µî¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÏ´Â ºÐÀÚÁø´Ü ±â¼ú¿¡ ´ëÇØ Á¶»çÇϰí, °¢Á¾ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ±â¹Ý ±â¼ú, Çü±¤µ¿¼Ò±³Àâ¹ý(FISH), ÆéŸÀ̵åÇÙ»ê(PNA), DNAÀÇ Àü±âÈÇаËÃâ, ¹ÙÀÌ¿ÀĨ, ³ª³ëÅ×Å©³î·¯Áö ¹× ÇÁ·ÎÅ׿À¹Í½º ±â¼ú¿¡ °üÇÑ ºÐ¼® µîÀ» ÀüÇØµå¸³´Ï´Ù. |
|
¼¼Æ÷Ä¡·á : ±â¼ú, ½ÃÀå, ±â¾÷ Cell Therapy - Technologies, Markets and Companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ÀÇ·áȰµ¿¿¡ ÀÖ¾î ÀÌ¹Ì Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ´Â ¼¼Æ÷Ä¡·á ±â¼ú¿¡ ´ëÇØ Á¶»çÇϰí, â¾à¿¡¼ ¼¼Æ÷ÀÇ ¿ªÇÒ ºÐ¼®, ¼¼Æ÷Ä¡·á ½ÃÀåÀÇ °ü·Ã ±â¾÷, Çмú±â°üÀÇ Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù. |
|
ÇÁ·ÎÅ׿À¹Í½º : ±â¼ú¡¤½ÃÀ塤±â¾÷ Proteomics - Technologies, Markets and Companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| Æ÷½ºÆ®°Ô³ð ½Ã´ëÀÇ Ã¢¾à, ºÐÀÚ Áø´Ü, ÀÇ·á Ȱµ¿¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÏ´Â ÇÁ·ÎÅ׿À¹Í½º ±â¼ú¿¡ ´ëÇØ Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
½Å°æ º¸È£ : ÀǾàǰ¡¤½ÃÀ塤±â¾÷ Neuroprotection - Drugs, Markets and Companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ¹ßÀÛÀ̳ª ½Å°æ°è ¼Õ»ó µîÀÇ ±Þ¼º Áúȯ, ½Å°æº¯¼º ÀåÇØ µîÀÇ ¸¸¼º ÁúȯÀÇ Ä¡·á¿¡ ÀÖ¾î¼ ½Å°æ º¸È£ÀÇ ¿ªÇÒ¿¡ ´ëÇØ Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
°æÇÇ ¾à¹°Àü´Þ(Drug Delivery) : ±â¼ú¡¤½ÃÀ塤±â¾÷ Transdermal Drug Delivery - Technologies, Markets, and Companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| °¢Á¾ °æÇÇ ¾à¹°Àü´Þ(Drug Delievery)ÀÇ ±â¼ú°ú ½ÃÀå¿¡ °üÇÑ Á¶»ç ³»¿ëÀ» °ü·Ã ±â¾÷ Á¤º¸¿Í ÇÔ²² ÀüÇØµå¸³´Ï´Ù. |
|
µ¿¹° »ý¸í°øÇÐ : ±â¼ú, ½ÃÀå, ±â¾÷ Animal Biotechnology - Technologies, Markets and Companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| µ¿¹° »ý¸í°øÇаú ±×°ÍÀÇ ¼öÀÇÇÐ ¹× ÀǾàǰ ºÐ¾ß¿¡ ´ëÇÑ Àû¿ë, ½ÄǰÁ¦Á¶ ºÐ¾ß¿¡ ´ëÇÑ Àû¿ë µîÀÇ µ¿ÇâÀ» Á¶»ç ºÐ¼®ÇÏ°í ±â¼ú°³¿ä, °¢Á¾ ¾ÖÇø®ÄÉÀÌ¼Ç ½ÃÀå, À±¸®¼º, °úÁ¦, ½ÃÀ强Àå ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
¸ÂÃãÇü ÀÇ·á(Personalized Medicine) : °úÇÐÀû¡¤»ó¾÷Àû »óȲ Personalized Medicine - scientific & commercial aspects |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ¾à¸® °Ô³ë¹Í½º, ¾à¸® À¯ÀüÇÐ, ¾à¸® ÇÁ·ÎÅ׿À¹Í½º ¹× ´ë»çÇп¡ ±Ù°ÅÇÑ ¸ÂÃãÇü ÀÇ·á(Personalized Medicine)ÀÇ ÃֽŠ»óȲ¿¡ ´ëÇØ Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¾ÏÀÇ ¾à¹°Àü´Þ(Drug Delivery) : ±â¼ú, ½ÃÀå, ±â¾÷ Drug Delivery in Cancer - technologies, markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ¾ÏÄ¡·á ºÐ¾ßÀÇ ¾à¹°Àü´Þ(Drug Delivery) ±â¼ú ¹× ½ÃÀå, °ü·Ã ±â¾÷ÀÇ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
RNAi(RNA °£¼·) : ±â¼ú, ½ÃÀå, ±â¾÷ RNAi - technologies, markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| RNAi¿Í ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå, ¾ÐŸ¸Ó, ¸®º¸ÀÚÀÓ, ÆéŸÀ̵åÇÙ»ê ¹× LNAÀ» ÀÌ¿ëÇÑ ±âŸ ¾ÈƼ¼¾½º ¾îÇÁ·ÎÄ¡¸¦ ºñ±³ ºÐ¼®Çϰí, °¢Á¾ RNAi ±â¼úÀÇ ÇØ¼³ ¹× °ü·Ã ±â¾÷ÀÇ Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù. |
|
À¯ÀüÀÚ Ä¡·á : ±â¼ú, ½ÃÀå, ±â¾÷ Gene Therapy - technologies, markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| À¯ÀüÀÚ Ä¡·á ±â¼ú ¹× °¢Á¾ Áúȯ ŸÀÔº° À¯ÀüÀÚ Ä¡·á µ¿Çâ, °ü·Ã ±â¾÷ÀÇ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
³ª³ë¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö : ¾ÖÇø®ÄÉÀ̼ǡ¤½ÃÀ塤±â¾÷ Nanobiotechnologies- applications, markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ³ª³ë¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿¡ °ü·ÃµÈ °¢Á¾ ±â¼ú ¹× ½Å¾à, ¾à¹°Àü´Þ(µå·¯±× µô¸®¹ö¸®, Drug Delivery), ÀÓ»ó ¾ÖÇø®ÄÉÀÌ¼Ç µî¿¡¼ÀÇ ³ª³ë¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ÀÌ¿ë µ¿Ç⠵ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¹ÙÀÌ¿À¸¶Ä¿ÀÇ ±â¼ú, ½ÃÀå, ±â¾÷ Biomarkers - technologies,markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ´Ù¾çÇÑ Á¾·ùÀÇ ¹ÙÀÌ¿À¸¶Ä¿ °³¿ä, ¹ÙÀÌ¿À¸¶Ä¿ ¹ßÀüÀ» À§ÇÑ °¢Á¾ ±â¼ú, °¢Á¾ Áúº´ ºÐ¾ß¿¡¼ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¿ªÇÒ µîÀ» Á¶»ç ºÐ¼®ÇÏ°í ±ÔÁ¦»óÀÇ °úÁ¦, ¹ÌÃÑÁ· ¿ä°Ç, ½ÃÀ强Àå ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
¼¼Æ÷À¯ÀüÇÐ(Cytogenetics) : ±â¼ú¡¤½ÃÀ塤±â¾÷ Cytogenetics - technologies,markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ¿°»öü ±¸Á¶ÀÇ ¼ö½Ä ¹× Áúȯ¿¡ °ü·ÃµÈ ÀÌ»óÀ» ƯÁ¤ÇÏ´Â ¼¼Æ÷À¯ÀüÇÐ(Cytogenetics)¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
Ç×¹ÙÀÌ·¯½º Ä¡·á : ±â¼ú¡¤½ÃÀ塤±â¾÷ Antiviral Therapeutics - technologies, markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| °¢Á¾ Ç×¹ÙÀÌ·¯½º Ä¡·á ±â¼ú, ½ÃÀå µ¿Çâ, ±â¾÷ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
¾Ï Áٱ⼼Æ÷ : Ä¡·á Àü·«°ú ÆÄÀÌÇÁ¶óÀÎ °³¹ß(2010³â) Targeting Cancer Stem Cells: Therapeutic Strategies and Pipeline Developments (2010) |
|
Pub Time : 2010/01 Published by : BioPharm Reports (Technology and Markets Ltd) |
| ¾Ï Áٱ⼼Æ÷¿¡ °üÇÑ ¼¼°èÀÇ ¿¬±¸ °³¹ß Ãֽе¿ÇâÀ» Æ÷°ýÀûÀ¸·Î °ËÁõÇÏ°í ºÐ¾ß¿¡ Âü°¡ÇÏ´Â ±â¾÷ µ¿Çâ ¹× Àü·«, °úÁ¦ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
Áß±¹ÀÇ ´ÜÀÏ Å¬·Ð Ç×ü ½ÃÀå Chinese Markets for Monoclonal Antibody |
|
Pub Time : 2010/01 Published by : Asia Market Information & Development Co. |
| Áß±¹ÀÇ °æÁ¦ µ¿Çâ, ´ÜÀÏ Å¬·Ð Ç×ü ½ÃÀåÀÇ ÅõÀÚ È¯°æ, »ê¾÷ÀÇ ¹ßÀü, ¼ö¿ä ¹× °ø±Þ, »ê¾÷ ±¸Á¶, ½ÃÀå ä³Î ¹× ÁÖ¿ä ±â¾÷ µî¿¡ ´ëÇØ »ó¼¼È÷ Á¶»çÇϰí, 2003³â ¹× 2008³âÀÇ ½ÇÀû, 2013³â ¹× 2018³âÀÇ Àå±â ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù. |
|
Áß±¹ÀÇ Ç÷¾×Á¦Á¦ ½ÃÀå Chinese Markets for Blood Products |
|
Pub Time : 2010/01 Published by : Asia Market Information & Development Co. |
| Áß±¹ÀÇ °æÁ¦ µ¿Çâ, Ç÷¾×Á¦Á¦ ½ÃÀåÀÇ ÅõÀÚ È¯°æ, »ê¾÷ÀÇ ¹ßÀü, ¼ö¿ä ¹× °ø±Þ, »ê¾÷ ±¸Á¶, ½ÃÀå ä³Î ¹× ÁÖ¿ä ±â¾÷ µî¿¡ ´ëÇØ »ó¼¼È÷ Á¶»çÇϰí, 2003³â ¹× 2008³âÀÇ ½ÇÀû, 2013³â ¹× 2018³âÀÇ Àå±â ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù. |
|
¼¼Æ÷Ä¡·á¸¦ À§ÇÑ Áٱ⼼Æ÷ ½ÃÀå : 2010³â Stem Cells for Cellular Therapy 2010 Market Report |
|
Pub Time : 2010/01 Published by : Select Biosciences, Ltd. |
| Áٱ⼼Æ÷ ½ÃÀåÀÇ µ¿ÇâÀ» Á¤¼ºÀû, Á¤·®ÀûÀ¸·Î ºÐ¼®Çϰí, Á¦Ç°º°, Áö¿ªº° ½ÃÀå ¿¹Ãø, Á¦´ëÇ÷ ÀºÇà ½ÃÀåÀÇ °³¿ä µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¸¶ÀÌÅ©·Î RNA ¿¬±¸ ½ÃÀå : 2010³â MicroRNA Research and Disease Associations 2010 Market Report |
|
Pub Time : 2010/01 Published by : Select Biosciences, Ltd. |
| ¸¶ÀÌÅ©·Î RNA(miRNA) ¿¬±¸ ½ÃÀåÀÇ µ¿ÇâÀ» Á¤¼ºÀû, Á¤·®ÀûÀ¸·Î ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð ¹× ¼ºÀå·ü, ÇâÈÄ ¿¹Ãø, ½ÃÀå ºÎ¹®º° µ¿Çâ, ½ÃÀåÀÇ ±âȸ, ¹ÌÃæÁ· ¿ä±¸¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
Á¦´ëÇ÷ ¾÷°èÀÇ ¼ºÀå±âȸ Capitalizing on Opportunities in Cord Blood Industry Growth |
|
Pub Time : 2010/01 Published by : BioInformant |
| Á¦´ëÇ÷ ÀºÇà ¾÷°èÀÇ °ú°Å 12°³¿ù°£ ½ÇÀû°ú ½Å±Ô Âü°¡ µ¿Çâ, ¾÷°è Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ, ±¹°¡º° ºñ¿ë ºÐ¼® µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå : ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿Í ·¦¿Â¾îĨ(Lab-on-a-Chip) Global Biochip Markets: Microarrays and Lab-on-a-Chip |
|
Pub Time : 2010/01 Published by : BCC Research |
| ¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ¾÷°è¸¦ Á¶»ç ºÐ¼®Çϰí, ÇöÀç ¹× ÇâÈÄ¿¡ ÀÌ¿ëµÇ´Â ´Ù¾çÇÑ ¹ÙÀÌ¿ÀĨÀÇ ¿ëµµ, ½ÃÀåÀÇ ÇöȲ°ú 2014³â±îÁöÀÇ È®´ë ¿¹Ãø, Ãֽбâ¼ú µ¿Çâ, ¾÷°è¿¡ Âü°¡ÇÏ´Â ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö Àåºñ ½ÃÀå The Global Market for Equipment Used in Biotechnology Applications |
|
Pub Time : 2010/01 Published by : BCC Research |
| ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö Àåºñ ½ÃÀå¿¡ ´ëÇÑ 2007³â°ú 2008³âÀÇ ½ÇÀûÀ» Á¤¸®Çϰí, 2009³âºÎÅÍ 2014³â±îÁöÀÇ ¿¹Ãø°ú ¼ºÀå·ü, ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀϰú ƯÇã µ¿ÇâÀ» ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
´ÙÁߺм®(Multiplex Assays) : ¹ßÀüÇÏ´Â ±â¼ú, ÀÀ¿ë, ÇâÈÄÀÇ ¹æÇ⼺ Multiplex Assays: Evolving Technologies, Applications and Future Directions |
|
Pub Time : 2010/01 Published by : Insight Pharma Reports |
| ´ÙÁߺм®(Multiplex Assays) ºÐ¾ßÀÇ ÃÖ±Ù ¹ßÀü µ¿Çâ¿¡ ÃÊÁ¡À» ¸ÂÃß¾î µ¿ ±â¼úÀÇ ´Ù¾çÇÑ ºÐ¾ß¿¡ÀÇ ÀÀ¿ë µ¿Çâ, ÇâÈÄÀÇ ¹ßÀü Àü¸Á µîÀ» ÀüÇØµå¸³´Ï´Ù. |
|
À¯ÀüÀÚÄ¡·á : 20³âÀÇ ÀÓ»ó°³¹ß Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development |
|
Pub Time : 2009/12 Published by : Datamonitor |
| ÇöÀçÀÇ À¯ÀüÀÚÄ¡·á °³¹ß ÆÄÀÌÇÁ¶óÀÎÀ» »ó¼¼È÷ ºÐ¼®ÇßÀ¸¸ç, ÁÖ¿ä ÀûÀÀÇ¥Àû°ú º» ºÐ¾ß¿¡¼ Ȱ¾àÇÏ´Â ±â¾÷À» ¼Ò°³ÇÏ¸é¼ ±â¼ú µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¸ÂÃãÇü ÀÇ·áÀÇ ¹Ì·¡»ó Business Strategy: Personalized Medicine Looking Forward |
|
Pub Time : 2009/12 Published by : Health Industry Insights |
| ¸ÂÃãÇü ÀÇ·áÀÇ ÇöÀç »óȲÀ» ¼³¸íÇϰí ÀÇ·á¾÷°è¿¡ °üÇÑ ´Ù¾çÇÑ ±â¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ µîÀ» ºÐ¼®ÇÏ¿© ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎ ¹× ÇâÈÄ ¹ßÀü ´Ü°è, ÁÖ¿ä ¼ºÀå ºÐ¾ß µîÀ» ÇØ¸íÇÏ°í °¢Á¾ ÀÇ·á °ü·Ã ±â¾÷¿¡ ´ëÇÑ Á¦¾ð µîÀ» ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ¹ÙÀÌ¿À ÇÃ¶ó½ºÆ½ ½ÃÀå Global Bio-based Plastics Market |
|
Pub Time : 2009/12 Published by : Frost & Sullivan |
| ¼¼°èÀÇ ¹ÙÀÌ¿À ÇÃ¶ó½ºÆ½ ½ÃÀåÀ» Ãë±ÞÇϸç, ÁÖ¿ä µ¿Çâ, ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀΰú ÀúÇØ¿äÀÎ, Àå·¡¼º µîÀ» ºÐ¼®ÇßÀ¸¸ç °¢Á¾ Á¦Ç°ÀÇ ½ÃÀå¿¡ ´ëÇØ¼µµ »ó¼¼È÷ °ËÅäÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¹Ì±¹ÀÇ µ¿¹Ý Áø´Ü ½ÃÀå U.S. Companion Diagnostics Markets |
|
Pub Time : 2009/12 Published by : Frost & Sullivan |
| ¹Ì±¹ÀÇ µ¿¹Ý Áø´Ü ½ÃÀå¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
Á¦¾à ºÎ¹®¿ë ±â¼ú ½ÃÀåÀÇ µ¿Çâ : 2010³â 2010 Trends to Watch: Pharmaceutical Technology |
|
Pub Time : 2009/12 Published by : Datamonitor |
| Á¦¾à ºÎ¹®ÀÇ ÁÖ¿ä º¯È¸¦ Á¶»çÇϰí, ÃÖ´ëÀÇ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÌ´Â µ¿Çâ, ÀÌ·¯ÇÑ ¹ßÀüÀÌ Á¦¾àȸ»ç¿Í ±â¼ú/¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ ½Ö¹æ¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú ±âȸ¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ¹Ì·¡ : 2015³â±îÁöÀÇ ½ÃÀå ¿¹Ãø, ±âȸ ºÐ¼® ¹× ±ÔÁ¦ µ¿Çâ The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways |
|
Pub Time : 2009/12 Published by : GBI Research |
| ¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇØ ¼³¸íÇÏ°í ¹Ì±¹, À¯·´, ÀϺ» ½ÃÀåÀÇ µ¿Çâ, Á¦³×¸¯ ÀǾàǰ°úÀÇ °æÇÕ, ±ÔÁ¦ µ¿Çâ ¹× ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ÀüÇØµå¸³´Ï´Ù. |
|
Drug Discovery¿¡¼ÀÇ DNA ½ÃÄö½Ì : ¾ÖÇø®ÄÉÀ̼ǡ¤Åø¡¤¼ºñ½º ½ÃÀå Àü¸Á ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ(40»ç) DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles |
|
Pub Time : 2009/12 Published by : Business Insights |
| DNA ½ÃÄö½Ì ±â¼úÀÇ ¹ßÀü µ¿Çâ°ú ½ÃÀå Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, DNA ½ÃÄö½ÌÀÇ ¹ßÀü °æÀ§, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÀúÇØ¿äÀÎ, Åø, ¼ºñ½º, ¾ÖÇø®ÄÉÀ̼Ç, Áö¿ª µî °¢Á¾ ¿ä¼Òº° ½ÃÀå ¼ºÀå ¿¹Ãø(¡2014³â), ½ÅÁ¦Ç°¡¤½Å±â¼ú¡¤½Å¼ºñ½ºÀÇ ÅõÀÔ µ¿Çâ, ÁÖ¿ä Æ¯Çã µ¥ÀÌÅÍ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
À¯ÀüÀÚ ÀçÁ¶ÇÕ Ä¡·á ¹× À¯ÀüÀÚ Á¶ÀÛ Ä¡·á Recombinant and Designer Therapeutics |
|
Pub Time : 2009/12 Published by : Technical Insights, Inc. |
| À¯ÀüÀÚ ÀçÁ¶ÇÕ Ä¡·á ¹× À¯ÀüÀÚ Á¶ÀÛ Ä¡·áÀÇ Ãֽе¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ Point of Care(POC) ½ÃÀå Point of Care Diagnostics |
|
Pub Time : 2009/12 Published by : BCC Research |
| ¼¼°è Point of Care(POC) ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °Ë»ç À¯Çü¡¤Áö¿ªº° ½ÃÀå ¼ºÀå ¿¹Ãø(¡2014³â), ÁÖ¿ä Á¦Á¶¾÷ÀÚÀÇ ½ÃÀå Á¡À¯À², °¢Á¾ ½ÃÀå ¿µÇâ¿äÀÎ, Ãâ½Ã Á¦Ç°ÀÇ °³¿ä, ÀÌ¿ë ±â¼ú, ÁÖ¿ä Âü°¡±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¾Ï°Ë»ç¿¡¼ÀÇ ºÐÀÚÁø´Ü Molecular Diagnostics in Cancer Testing |
|
Pub Time : 2009/12 Published by : Trimark Publications |
| ºÐÀÚÁø´ÜÀ¸·Î ¾Ë·ÁÁø ü¿Ü Áø´Ü ºÐ¾ß¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÏ°í ¾ÏÀÇ °Ë»ç ¹× Ä¡·á¿¡ ¾²ÀÌ´Â ºÐÀÚÁø´Ü ½ÃÀåÀÇ ±Ô¸ð ¹× ¼ºÀå µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¾Ï¿¡ ´ëÇÑ ¾ÆÆ÷Åä½Ã½º(Apotosis) Ä¡·á : »óÇ°È µ¿Çâ Apoptotic Therapeutics in Oncology - Where to Commercialize? |
|
Pub Time : 2009/11 Published by : BioSeeker Group AB |
| 171°³ ¾ÆÆ÷Åä½Ã½º(Apotosis) ¾àÁ¦ÀÇ °³¹ß Àü·«¿¡ ´ëÇØ ºÐ¼®Çϰí, Á¦¾àȸ»çÀÇ Æ÷Æ®Æú¸®¿À °èȹ°ú ½ÅÁ¦Ç° °³¹ß °èȹÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå : µ¿Çâ°ú ±âȸ Biochips - A Global Update of Market Trends & Opportunities |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ¼¼°è ¹ÙÀÌ¿ÀĨ »ê¾÷ÀÇ °³¿ä, Á¦Ç°/¾ÖÇø®ÄÉÀ̼Ç, °¢±¹ ½ÃÀåÀÇ µ¿Çâ µîÀ» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÇÁ·ÎÅ׿À¹Í½º : ¼¼°è ½ÃÀåÀÇ µ¿Çâ Proteomics - International Market Trends |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ÇÁ·ÎÅ׿À¹Í½ºÀÇ °³¿ä¿Í ¼¼°è ½ÃÀå µ¿Çâ, ±â¼ú °³¹ß°ú ÀÀ¿ë ºÐ¾ß, ÃÖ±ÙÀÇ ¾÷°è µ¿Çâ, ¼¼°èÀÇ Áö¿ªº° ½ÃÀå µ¿Çâ, Âü°¡ ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ½ÃÀå Bioinformatics - A Global Market Intelligence Report |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ¼¼°è ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ½ÃÀåÀÇ Áö¿ª/±¹°¡º° ½ÃÀå °³¿ä¿Í ¿¹Ãø, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ÀüÇØµå¸³´Ï´Ù. |
|
۶ö ±â¼ú : ¼¼°èÀÇ ±â¼ú/½ÃÀå µ¿Çâ Chiral Technology - International Technology & Market Trends |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ¼¼°èÀÇ Å°¶ö ±â¼ú ½ÃÀå °³¿ä ¹× ¹ßÀü µ¿Çâ, ±ÔÁ¦ ȯ°æ µî¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀϰú ÇÔ²² ÀüÇØµå¸³´Ï´Ù. |
|
Äݶó°Õ ¹× È÷¾Ë·ç·Ð»ê ±â¹Ý »ýüÀûÀÀÀç·á : ¼¼°èÀÇ µ¿Çâ Collagen and HA-based Biomaterials - Global Trends |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| Äݶó°Õ ¹× È÷¾Ë·ç·Ð»ê ±â¹Ý »ýüÀûÀÀÀç·á ½ÃÀåÀÇ µ¿Çâ¿¡ ´ëÇØ ºÐ¼®Çϰí, »ýüÀûÀÀÀç·áÀÇ ¿¬±¸ °³¹ß µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏ, °¢±¹ ½ÃÀ庰 µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ¼ºÀåÀÎÀÚ(Ç÷¾× ¹× Á¶Á÷) ½ÃÀå Growth Factors (Blood And Tissue) - A World Report |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ¼¼°èÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ±× ¿ªÇÒ°ú ÀÀ¿ë ºÐ¾ß, ÇâÈÄÀÇ °³¹ß µ¿Çâ, ¾÷°è ³»ÀÇ °æÇÕ µ¿Çâ, °¢±¹ ½ÃÀ庰 µ¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ Å°³ª¾ÆÁ¦ ÀúÇØÁ¦ ½ÃÀå Kinase Inhibitors: Global Markets |
|
Pub Time : 2009/11 Published by : BCC Research |
| ¼¼°è Ű³ª¾ÆÁ¦ ÀúÇØÁ¦ ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, Á¦Ç° À¯Çü¡¤Àû¿ë Áúº´ ±¸ºÐº° ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¡2014³â), ½ÃÆÇ Á¦Ç°°ú °³¹ßÁßÀÎ Á¦Ç°ÀÇ °³¿ä, ÁÖ¿ä ±â¾÷°ú ½ÃÀå Á¡À¯À², ±¹Á¦Àû Àü¸Á, ÇâÈÄÀÇ ¹æÇ⼺ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
³ó¾÷¿¡¼ÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö : ¼¼°è ½ÃÀå µ¿Çâ Agricultural Biotechnology - Global Market Trends |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ³ó¾÷¿¡¼ÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿¡ ´ëÇØ ºÐ¼®Çϰí À¯ÀüÀÚ º¯Çü ÀÛ¹°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀǽÄ, ½ÃÀåÀÇ µ¿Çâ°ú ÇâÈÄ ¿¹Ãø, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö°¡ »çȸ °æÁ¦¿Í À±¸®, ȯ°æ, Àΰ£¿¡°Ô ¹ÌÄ¡´Â ¿µÇâ, ±ÔÁ¦ µ¿Çâ, °¢±¹ ½ÃÀåÀÇ µ¿Çâ¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ÀÚµ¿¡¤½Å¼Ó ¹Ì»ý¹° °Ë»ç ½ÃÀå Automated and Rapid Microbiological Tests - A Worldwide Market Review |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ¼¼°è ÀÚµ¿¡¤½Å¼Ó ¹Ì»ý¹° °Ë»ç ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±¸Á¶, °¢Á¾ ½ÃÀå ¿µÇâ¿äÀÎ, ÁÖ¿ä Á¦Ç°ÀÇ °³¿ä(¾ÖÇø®ÄÉÀÌ¼Ç À¯Çüº°), ÁÖ¿ä ±â¾÷ÀÇ ´ëó, ¼¼°è ¹× ÁÖ¿ä ±¹°¡ ½ÃÀåÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¡2015³â), ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ »ýüÀûÇÕ¼º Àç·á ½ÃÀå Biocompatible Materials - A Global Market Trajectory |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ¼¼°è »ýüÀûÇÕ¼º Àç·á ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, Àç·á ±¸ºÐ °³¿ä, Á¦Ç° µ¿Çâ, R&D »óȲ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ, ¼¼°è ¹× ÁÖ¿ä ±¹°¡ ½ÃÀåÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¡2015³â), ±ÔÁ¦ ȯ°æ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
| |
Page: 1 2 3 4 5 6 7 8 9 10 |
Next >>
|
|
|